Pediatric Hematology And Oncology

Pediatric Hematology And Oncology英文簡介

PHO: Pediatric Hematology and Oncology covers all aspects of research and patient management within the area of blood disorders and malignant diseases of childhood. Our goal is to make PHO: Pediatric Hematology and Oncology the premier journal for the international community of clinicians and scientists who together aim to define optimal therapeutic strategies for children and young adults with cancer and blood disorders. The journal supports articles that address research in diverse clinical settings, exceptional case studies/series that add novel insights into pathogenesis and/or clinical care, and reviews highlighting discoveries and challenges emerging from consortia and conferences. Clinical studies as well as basic and translational research reports regarding cancer pathogenesis, genetics, molecular diagnostics, pharmacology, stem cells, molecular targeting, cellular and immune therapies and transplantation are of interest. Papers with a focus on supportive care, late effects and on related ethical, legal, psychological, social, cultural, or historical aspects of these fields are also appreciated. Reviews on important developments in the field are welcome. Articles from scientists and clinicians across the international community of Pediatric Hematology and Oncology are considered for publication. The journal is not dependent on or connected with any organization or society. All submissions undergo rigorous peer review prior to publication. Our Editorial Board includes experts in Pediatric Hematology and Oncology representing a wide range of academic and geographic diversity.

Pediatric Hematology And Oncology中文簡介

《Pediatric Hematology And Oncology》是一本由TAYLOR & FRANCIS INC出版商出版的專業(yè)醫(yī)學期刊，該刊創(chuàng)刊于1986年，刊期Bimonthly，該刊已被國際權威數據庫SCI、SCIE收錄。在中科院最新升級版分區(qū)表中，該刊分區(qū)信息為大類學科：醫(yī)學 4區(qū)，小類學科：血液學 4區(qū)；腫瘤學 4區(qū)；兒科 4區(qū)；在JCR（Journal Citation Reports）分區(qū)等級為Q3。該刊發(fā)文范圍涵蓋血液學等領域，旨在及時、準確、全面地報道國內外血液學工作者在該領域取得的最新研究成果、工作進展及學術動態(tài)、技術革新等，促進學術交流，鼓勵學術創(chuàng)新。2021年影響因子為2.07，平均審稿速度較慢,6-12周。

中科院分區(qū)最新升級版（當前數據版本：2021年12月最新升級版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	4區(qū)	HEMATOLOGY 血液學 ONCOLOGY 腫瘤學 PEDIATRICS 兒科	4區(qū) 4區(qū) 4區(qū)	否	否

中科院分區(qū)最新基礎版（當前數據版本：2021年12月最新基礎版）

大類學科	分區(qū)	小類學科	分區(qū)	Top期刊	綜述期刊
醫(yī)學	4區(qū)	HEMATOLOGY 血液學 ONCOLOGY 腫瘤學 PEDIATRICS 兒科	4區(qū) 4區(qū) 4區(qū)	否	否

中科院JCR分區(qū)歷年趨勢圖

JCR分區(qū)（當前數據版本：2021-2022年最新版）

JCR分區(qū)等級	JCR所屬學科	分區(qū)	影響因子
Q3	PEDIATRICS	Q3	2.07
	HEMATOLOGY	Q4
	ONCOLOGY	Q4

期刊指數

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
2.07	38	1.81%	92.31%	未開放	較慢,6-12周

IF值(影響因子)趨勢圖